FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/02/063340 [Registered on: 29/02/2024] Trial Registered Prospectively
Last Modified On: 21/02/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   To compare the efficacy of bupivacaine and levobupivacaine in spinal anaesthesia for elective caesarean section  
Scientific Title of Study   Comparison of efficacy of intrathecal bupivacaine heavy (0.5%) and levobupivacaine heavy (0.5%) for elective caesarean section 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Anagha V Harlapur 
Designation  Junior resident -3 
Affiliation  BJGMC and Sassoon hospital 
Address  BJGMC and Sassoon hospital, Department of Anaesthesia, Room number 11

Pune
MAHARASHTRA
411001
India 
Phone  07337857322  
Fax    
Email  anaghavh@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Surekha Shinde 
Designation  Professor 
Affiliation  BJGMC and Sassoon hospital 
Address  BJGMC and Sassoon hospital, Department of Anaesthesia

Pune
MAHARASHTRA
411001
India 
Phone  07337857322  
Fax    
Email  sureshinde@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Anagha V Harlapur 
Designation  Junior resident -3 
Affiliation  BJGMC and Sassoon hospital 
Address  BJGMC and Sassoon hospital, Department of Anaesthesia, Room number 11

Pune
MAHARASHTRA
411001
India 
Phone  07337857322  
Fax    
Email  anaghavh@gmail.com  
 
Source of Monetary or Material Support  
BJGMC and Sassoon hospital, Jai Prakash Narayan road, Pune station road, Maharashtra 411001 
 
Primary Sponsor  
Name  Anagha V Harlapur 
Address  Lateral hostel room number 426, BJGMC and Sassoon hospital, opposite to Bank of baroda pune- 411001 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Anagha V Harlapur   BJGMC and Sassoon hospital   Department of Anaesthesia, Room number 11
Pune
MAHARASHTRA 
7337857322

anaghavh@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics committee B J government medical college and Sassoon general hospital Pune  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  Pregnant women of ASA grade 2 
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Spinal anaesthesia   Bupivacaine heavy (0.5%) is given intrathecally to induce spinal anaesthesia and levobupivacaine heavy (0.5%) is also given intrathecally and the effects are compared . Duration is half an hour. 
Comparator Agent  Spinal anaesthesia  Comparison between bupivacaine heavy (0.5%) and levobupivacaine heavy (0.5%) in spinal anaesthesia for elective caesarean section. Both are local anaesthetic agents used intrathecally . Duration is half an hour. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  30.00 Year(s)
Gender  Female 
Details  Age 18-30 years
ASA grading I and II
Elective caesarean section surgical section 
 
ExclusionCriteria 
Details  Patient who refused to give consent.
A Documented sensitivity to drug in the past.
Bleeding diathesis and coagulopathy.
Age less than 18 and more than 30.
ASA grading III and IV.
Patient on anti hypertensive, anxiolytics, and anti epileptic.
Morbidly obese.
Patients for emergency lscs.
Patients with neurological and psychiatric illness.
Patients with spinal deformity.
Local site infections.
 
 
Method of Generating Random Sequence   Permuted block randomization, fixed 
Method of Concealment   Alternation 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
The onset of action
Duration of sensory blockade
Duration of motor blockade
Quality of anaesthesia
Hemodynamic alterations
Adverse effects 
Measured for half an hour every five minutes 
 
Secondary Outcome  
Outcome  TimePoints 
Pruritus
Sedation
Respiratory depression  
Half an hour for every 5 minutes 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   04/03/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="5"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Bupivacaine is the most commonly used drug for spinal anaesthesia. Plain Bupivacaine is hypobaric compared to CSF and is made heavy by addition of 8% glucose.
It is known to cause hypotension, bradycardia even sudden cardiac death. Levobupivacaine is pure enantiomer of bupivacaine and is truly isobaric with CSF of pregnant women. It causes less cardiotoxicity and is more specific for sensory blockade than motor blockade.
 
Close